Application no. and date | 08725157.5 (espacenet) (Federated) (European Patent Register), 20080205 | Patent/reg. no. and date | DK/EP 2148691, 20150520 | Publication date | 20100203 | Priority no. and date | US 899474 P, 20070205 | EP pub. no. and date |
EP 2148691 20100203 | Effective date | | Applicant/owner | Apellis Pharmaceuticals, Inc., 6400 Westwind Way Suite A
Crestwood, KY 40014, US | Applicant ref. no. | P56577DK01 | Inventor | FRANCOIS, Cedric, 1434 Goddard Avenue
Louisville, KY 40204, US, DESCHATELETS, Pascal, 11031 Indian Legends, Apt. 202
Louisville, KY 40241, US, OLSON, Paul, 1202 Cherokee Road, Apt. 2
Louisville, KY 40204, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 38/12 (2006.01) , A61K 38/17 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , C07K 14/435 (2006.01) , C07K 7/64 (2006.01) | Title | Compstatinanaloger til anvendelse i behandingen af inflammatoriske tilstande i åndedrætssystemet | Int. application no. | US2008001483 | Int. publication no. | WO2008097525 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|